On June 2, 2022, Mr. Han Xu, Chairman of Ruikang Pharmaceutical Group, Mr. Ma Lewei, General Manager of Strategic Marketing Department, and other leaders visited Jerei, accompanied by Mr. Mou Wenqing, President of Jerei, visited the company's digital center, and the two sides held a discussion and meeting on the application of Fulima Cloud in the digital transformation of enterprises.
Founded in 2004 with a registered capital of 1.5 billion RMB, Ruikang Pharmaceutical Group was listed on Shenzhen A-share market in 2011. With more than 100 subsidiaries and 9,000 employees, Ruikang Pharmaceutical Group is a company that sells medicines, medical devices, and medical consumables to medical institutions nationwide, and has eight business segments, including distribution of medicines and devices, academic services, medical diagnostics, financial science and technology, traditional Chinese medicine, digital healthcare, specialized logistics, and comprehensive medical devices. At the same time, it is a leading pharmaceutical distribution company with eight business segments, including pharmaceutical distribution, academic services, medical diagnostics, financial technology, traditional Chinese medicine, digital healthcare, specialized logistics and comprehensive equipment, etc. Its sales network covers 31 provinces and cities across the country, and it directly serves nearly 60,000 healthcare institutions, and its business covers almost all domestic and foreign manufacturers above the scale.
Under the environment of continuous innovation and development of the pharmaceutical industry, digital transformation has become a necessary path for pharmaceutical enterprises to improve innovation ability, efficient collaboration, reduce costs and increase efficiency, and build competitive advantages, and the traditional pharmaceutical industry is rapidly approaching digitalization. As a large domestic pharmaceutical distribution enterprise, Ruikang Pharmaceutical Group has a deep understanding of the importance of digital transformation in the new development stage of the enterprise, and this visit to Jerei is expected to explore the new mode of cooperation in pharmaceutical digitalization through exchanges and mutual understanding.
During the visit, Mr. Mou Wenqing, President of Jerei, gave a detailed introduction of Jerei's development history, as well as Fulima Cloud and Digital Twin technology, and showed the cases of customers in various fields over the years, and the two sides conducted in-depth discussions on the cooperation in the fields of digital center and informatization consulting.
Mr. Han spoke highly of Jerei's innovative achievements in information technology consulting business, exploration of digital twins in the medical industry, and application in the pharmaceutical industry, and looked forward to diversified cooperation with Jerei in the future, jointly promoting the use of digital twins in the pharmaceutical industry and exploring a new route for enterprise digital transformation in the digital era.
As a digital technology leader, Jerei relies on its own industrial Internet platform - Fulima Cloud, from the three dimensions of digital marketing, digital production, digital control, to help enterprises in digital transformation, empowering the manufacturing industry to digital transformation, and continue to inject new momentum for the development of digital transformation of the pharmaceutical industry.
Jerei's mature pharmaceutical industry digital solutions have been deeply integrated with many pharmaceutical companies in digital transformation. In the future, Jerei will give full play to its own advantages, integrate the digital twin resources, play the massive data cross-platform multi-domain rich application scenarios, according to the actual situation of the pharmaceutical enterprises, hand in hand with more cooperative enterprises, with continuous innovation of digital technology, continue to empower the pharmaceutical industry digital transformation and upgrading.
